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Abstract 
Background:  Anaemia of chronic disease 
(ACD) is the second most prevalent type of anaemia. 
Causes can be chronic infections, autoimmune 
diseases, malignancies and is characterized by 
pathologic iron homeostasis, impaired 
erythropoiesis and blunted erythropoietin response. 
Materials and Methods:  This retrospective 
case series study was conducted in Department of 
Pathology, Benazir Bhutto Hospital Rawalpindi 
where all the consecutive cases of ACD diagnosed 
by peripheral blood smear and bone marrow slide 
examination, presented during 2014-2016 were 
studied. The presenting complaints, physical 
examination findings, complete blood count, bone 
marrow biopsy, and provisional diagnosis were 
noted. Patients with other types of anaemia were 
excluded. 
Results: In our study of 51 cases, 27(52.9%) 
were males and 24(47%) were females. Median age 
was 35 years. Most common age group involved was 
8-25 years (25.39%). Fever was the commonest 
complaint (68.6%) followed by weight loss (37.2%). 
Commonest physical examination finding was pallor 
(90.2%) and hepatomegaly (37.2%). Severe anaemia 
(Hb≤8g/dl) was present in 43.1% cases. RBCs were 
microcytic hypochromic in 43.1% of patients. 
Thrombocytopenia (platelets <150,000/mm3) was a 
finding in 49% of patients. Hemophagocytes were 
present in 49% of cases. Aetiology was undiagnosed 
in 68.6% of cases. 45.09% patients had a previous 
history of blood transfusion. 
Conclusion:  Fever is the commonest 
presenting complaint. Most of the cases have 
unknown aetiology. A high number of patients with 
severe anaemia is not in accordance with ACD as a 
disease of mild anaemia. This reflects inappropriate 
recognition of ACD. 
 
 
Introduction 
Anaemia is a global disorder. It is defined as reduction 
of total circulating red cell mass below normal limits. 
Multifactorial in origin, Anaemia of chronic disease 
(ACD) is the commonest type of anaemia after iron 
deficiency anaemia and is most frequently 
encountered anaemia in hospital settings. As its name 
implies it is due to chronic diseases which can be 
infections (bacterial, viral and fungal), 
cancers(hematologic and solid tumours) and 
autoimmune disorders(systemic lupus erythematous, 
rheumatoid arthritis and inflammatory bowel 
disease).Interleukin-1(IL-1), Interleukin-6(IL-6) and 
Tumour Necrosis Factor-alpha (TNF-α) are mainly 
involved in its pathogenesis which induce the 
formation of hepcidin, an acute phase protein which 
impairs the function of ferroportin ,hence blocking the 
export of iron from macrophages1,2 .Interleukin-10(IL-
10) increases the formation of transferrin receptors 
hence increasing the uptake of iron in the monocytes.  
It is a paradoxical condition in which body is not 
deficient of iron but due to accumulation and 
entrapment in the macrophages cannot be used for 
erythropoiesis. Anaemia of chronic disease is 
characterized by pathologic iron homeostasis, 
impaired erythropoiesis and blunted erythropoietin 
response. Laboratory findings which differentiate it 
from iron deficiency anaemia are increased ferritin 
levels and decreased total iron binding capacity. There 
is also increase in the cytokines level in this type1 
Anaemia of chronic disease is a hypo proliferative type 
of anaemia primarily occurring in response to 
inflammatory cytokines which are TNF-α, IL-1 and IL-
6. There is also shortening of life of RBCs3,4. There is 
low serum iron, decreased serum transferrin and 
transferrin saturation. There is increased erythrocyte 
free protoporphyrin and iron absorption is reduced. 
Iron given intravenously is sequestered in 
reticuloendothelial system4. Iron used alone causes 
growth of microorganisms and tumour cells5 
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Anaemia of chronic disease can be diagnosed on the 
basis of bone marrow biopsy. On iron staining there is 
presence of increased iron in bone marrow histiocytes 
with the absence in sideroblasts and siderocytes6. 
Treatment options mainly include treatment of the 
underlying cause, blood transfusions in cases of severe 
anaemia (Hb≤8g/dl), erythropoietic agents1 and anti-
interleukin-6 treatment7. Blood transfusions causes 
iron overload which has shown to increase the 
mortality over years8. Introduction of Recombinant 
human erythropoietin has resulted in decreased blood 
transfusions in hospital settings9. 
The objective of our study was to assess the clinical 
presentations, laboratory findings and etiological 
factors of Anaemia of chronic disease. 
 
Patients and Methods 
This retrospective case series study was conducted in 
the Department of Pathology, Benazir Bhutto Hospital, 
Rawalpindi from January 2014 – December 2016. All 
consecutive cases of Anaemia of Chronic Disease, 
which were 51 in number, presented during this time 
period were included in this study. 
Anaemia of Chronic Disease was diagnosed on the 
basis of peripheral blood smear staining along with 
bone marrow aspirate staining.  Patients specifically 
having increased iron in bone marrow histiocytes and 
decreased iron in siderocytes and sideroblasts were 
included. Patients having any other type of anaemia 
were excluded. 
Blood sample was taken from all the patients in the 
morning. Complete blood count was assessed by an 
automated blood analyser. The haemoglobin levels, 
red blood cell count, white blood cell count and 
platelet count were noted. A thin smear blood slide 
was made, stained with Giemsa stain, and seen under 
light microscope for peripheral blood picture. 
Reticulocytes were assessed using new methylene blue 
(NMB) stained slide. 
Bone marrow aspiration of all the patients was done 
from anterior superior iliac spine. Two slides from a 
single aspirate were made. Giemsa staining was 
performed to assess the status of myelopoiesis, 
erythropoiesis, cellularity, and the presence of 
megakaryocytes and hemophagocytes [Figure I]. The 
second slide was stained with Prussian Blue stain for 
iron and was used to assess the iron status in 
histiocytes, siderocytes and sideroblasts [Figure II].  
Males having haemoglobin less than 13g/dl and 
females less than 11g/dl were considered anaemic. 
World Health Organization criteria for anaemia 
severity was used to categorize the patient’s 
haemoglobin levels, according to which haemoglobin 
≥9.5g/dl is classified as mild, haemoglobin 8-9.5gdl as 
moderate and hemoglobin≤8g/dl as severe anaemic. 
The presenting complaints of the patients were noted 
and physical examination findings, including 
generalized appearance, any swellings, 
lymphadenopathy and liver and spleen palpation was 
performed and noted. History of blood transfusion, if 
any, was noted along with the provisional diagnosis of 
the patients from the referring department. The data 
was entered in Microsoft Excel 2007 and descriptive 
statistics were calculated.  
 
Figure I: A hemophagocyte is engulfing the RBCs. In 
our study 49% patients had hemophagocytosis. 
Giemsa stain 40X. inset 100X 
 
Figure II: Iron increased in the bone marrow fragments 
(blue). Prussian blue stain 40X 
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Results 
Out of the 51 cases presented in 3 years span (2014-16), 
27(52.9%) were males and 24(47%) were females with 
a male to female ratio of 9:8 The age of the patients 
ranged from 8 years to 90 years with 41.17% patients 
below the age of 25 years. Median age was 35 years 
[Table no. I].  
Table no.I Demographic Details of Patients (n=51) 
Parameter No. (%) 
Gender 
Male 27(53) 
Female 24 (47) 
Age(Years)  
Less than 25 21(41.17) 
25-50 19(37.25) 
Above 50 11(21.56) 
Fever was the commonest presenting complaint 
(68.6%) followed by weight loss (37.2%) and 
abdominal pain (29.4%) [Figure III]. On physical 
examination, 90.1% patients were pallor, 37.2% had 
hepatomegaly and 23.5% had splenomegaly. [Figure 
IV] 
 
 
Figure III: Presenting Complaints of Patients with 
ACD 
 
Figure IV: Physical Examination Findings in patients 
of ACD 
 
Haemoglobin was assessed from complete blood count 
reports. Mild anaemia (Hb>9.5g/dl) was present in 
31.3% of patients.25.4% had moderate anaemia (Hb 8-
9.5g/dl) and severe anaemia (Hb<8g/dl) was found in 
43.1% of patients. Mean haemoglobin was 8.4 ± 1.8 
g/dl. Red blood cell morphology was normocytic 
normochromic in 56.9% and microcytic hypochromic 
in 43.1% of patients. On peripheral blood giemsa 
staining, 43.1% patients had reticulocytopenia 
(reticulocytes<0.5%).45.09% patients had a history of 
blood transfusion. Leucocytopenia 
(leukocytes<4000/mm3) was present in 29.4% of 
patients. Thrombocytopenia (platelets< 150,000/mm3) 
was obvious in 49% of patients. Erythropoiesis was 
normal in 66.6% patients. Hemophagocytes were 
present in 49% of cases. [Table II] 
Table No.II: Laboratory Findings in Patients(n=51) 
Parameter No. (%) 
Degree of Anaemia 
Severe Hb <8g/dl 22(43.1) 
Moderate Hb 8-9.5g/dl 13(25.4) 
Mild Hb >9.5g/dl 16(31.3) 
RBC Morphology 
Normocytic Normochromic 29(56.9) 
Microcytic Hypochromic 22(43.1) 
History of Blood 
Transfusion 
23(45.09) 
Reticulocytopenia (less than 
0.5%) 
22(43.1) 
 
Total leukocyte count 
Less than 4000/mm3 15(29.4) 
4000-10000/mm3 31(60.7) 
Above 10000/mm3 5(9.8) 
Platelets  
Less than 150,000/mm3 25(49) 
150,000-400,000/mm3 19(37.2) 
Above 400,000/mm3 7(13.72) 
Bone Marrow 
Cellularity 
Normocellular 23(45.09) 
Hypercellular 18(35.2) 
Hypocellular 10(19.6) 
Erythropoiesis 
Normal 34(66.6) 
Hyperplastic 14(27.4) 
Depressed 3(5.88) 
Myelopoiesis 
Normal 32(68.6) 
Hyperplastic 19(37.25) 
Hemophagocytosis 25(49) 
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Iron 
Present in Macrophages 51(100) 
Absence in siderocytes and 
sideroblasts 
51(100) 
 
Aetiology was undiagnosed in 68.6% of cases, 
followed by typhoid and tuberculosis (7.8% each). 
[Table III] 
Table No.III: Causes of Anaemia of Chronic Disease 
(n=51) 
CAUSE No. (%) 
Unknown aetiology 35(68.6) 
Typhoid 4(7.8) 
Tuberculosis 4(7.8) 
Hepatitis C 2(3.9) 
Carcinoma of Head of 
Pancreas 
1(1.96) 
Gastric carcinoma 1(1.96) 
Metastatic bone disease 1(1.96) 
Diabetes Mellitus 1(1.96) 
Renal parenchymal disease 1(1.96) 
Inflammatory Bowel 
Disease 
1(1.96) 
 
Discussion 
ACD is normocytic normochromic type of anaemia but 
longstanding disease can change its morphology to 
microcytic hypochromic type1. Our results showed 
that 43.1% cases had microcytic hypochromic blood 
picture which is in accordance with a study which 
predicted the values between 30-50%10. Another study 
indicated this value to be 39.7%. Our results showed 
that 68.6% patients presented with fever which is in 
accordance with a study conducted in Rawalpindi 
having 51.4% patients with fever.11 In our study 45% 
patients had history of blood transfusion which is in 
accordance with the same study having values of 
48.6%11. 68.6% cases in our study have no diagnosed 
chronic disease at the time of their presentation which 
is higher than a previous study conducted in the 
region having values of 57.1%11. 4 cases of ACD had 
typhoid which is supported by a study which showed 
that anaemia and increased activity of histiocytes is 
associated with typhoid12. Tuberculosis is one of the 
commonest causes of ACD. Our study showed that 
7.8% cases of ACD had Tuberculosis. A Korean study 
showed that 31.9% patients of tuberculosis had 
anemia13.A study in Brazil where tuberculosis is 
endemic, showed that 89.2% of the patients had 
anemia14.There were two cases of malignancy in our 
study which is in accordance with the causes of ACD 
mentioned before1. There was a case of inflammatory 
bowel disease (IBD) in our study. IBD is always 
associated with anaemia and is a combination of iron 
deficiency anaemia and ACD. 30 % of patients have 
hemoglobin below 12g/dl15,16. ACD is itself 
ameliorated on treating the underlying chronic disease 
although it is invariably the most difficult of all types 
of anaemia to treat3,4,17,18. Hepcidin is key acute phase 
protein involved in pathogenesis of ACD. It causes 
trapping of iron in macrophages and hepatocytes 
hence causing hypoferremia. Hepcidin antagonists are 
an emerging field of research in treating ACD18-20.Due 
to lack of availability in our set-up, ferritin levels and 
total iron binding capacity values which are used 
worldwide to differentiate between ACD and iron 
deficiency anaemia, were not included in this study1. 
 
Conclusion 
Fever was the commonest presenting complaint and 
pallor was the commonest physical examination 
finding. 68.6% of patients had unknown aetiology. A 
high number of patients with severe anaemia is not in 
accordance with recognition of ACD as a disease of 
mild anaemia. This reflects inappropriate recognition 
of ACD. 
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